APACC logo
Meeting category
Date(s)
27 Jun 2024 - 29 Jun 2024
Location
Hong Kong, Hong Kong
Meeting type
Hybrid Conference
Organizer

APACC 2024

Related Enduring Materials

Enduring Materials
- parallel sessions

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

If you would like to see the program of either of the two pre-meetings, please visit their websites accordingly:

- 26 June: Asian Digital Health Innovations in HIV/STI Care Workshop

- 27 June: Asian Stigma & Discrimination Forum 2024

Plenary Session 1 - Opening Session - 13:30
Introduction - Challenges & Successes in the Region
Brigitte Quenum, MD, MPH
UNAIDS Asia Pacific, Thailand
Innovations in Implementation Strategies of Delivery Models
Ye Zhang, MSc, PhD
Nanjing Medical University, China
Fast Track City - Best Practice - Taiwan/ Taipei
Fast Track City - Best Practice - Philippines/ Quezon City
Rolando V. Cruz, DMD, PHSAE
Epidemiology and Surveillance Division (QCESD) in Quezon City, Philippines
Parallel Session 1: Advanced HIV Disease in Asia-Pacific -
Introduction on Advanced HIV Disease
Vu Quoc Dat, MD, PhD
Hanoi Medical University, Vietnam
Clinical Case 1 - AHD Related
Jacky Man Chun Chan, MBBS (HKU), FHKCP, FHKAM (Medicine), MPH (CUHK), FRCP (Edin)
Specialist in Infectious Diseases, Clinical Associate Professor (Honorary), Department of Medicine, University of Hong Kong, Hong Kong
Clinical Case 2 - AHD Related
Kate T. Leyritana, MD
Sustained Health Initiatives of the Philippines (SHIP), Philippines
Clinical Case 3 - OI Related (Fungal)
Romanee Chaiwarith, MD, MHS
Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Parallel Session 2: Abstract-Driven Session - Implementation -
#1: Optimizing real-time data flow from community outreach to public facility HIV confirmatory testing and treatment for key population clients in Ho Chi Minh City, Vietnam
Gia Hoang Tran
Vietnam
#2: Hybrid Model of Care: Looking at Lessons Learned in Blending In-person and Teleconsultation in an HIV Clinic in the Philippines through the RE-AIM Framework
Anna Maureen Dungca-Lorilla
Philippines
#3: Enhancing Same-Day ART Policy and Implementation at a Provincial Level through a National Contest: Short-Term and Long-Term Results from the Thailand Test and Treat Contest
Narukjaporn Thammajaruk
Thailand
#4: Enhancing treatment outcomes, mental health, and quality of life for stable people Living with HIV: a quasi-experimental study of a community-based antiretroviral therapy delivery model in Cambodia
Ziya Tian
Singapore
#5: Facilitators and Barriers to Mental Health Service Integration in Outpatient HIV Care: Insights from Women Living with HIV in Malaysia
Anjanna Kurkreja
Malaysia

Day 2: Friday 28 June 2024

Plenary Session 2: Brain & HIV - Neurocognitive Decline in Aging PLWHIV -
Assessment Tools / Research Translation in Clinical Practice
Lucette A. Cysique, MA, PhD
University of New South Wales, Kirby Institute and School of Psychology, Australia
Approaches in Managing Cognitive Decline in LMIC Settings
Phillip Chan, MBChB, MRCP (UK), FHKCP, FHKAM
Yale School of Medicine, United States
Parallel Session 3: Innovations in Diagnostic Testing -
Chairs:
Innovations in TB Diagnostics - FIND(India)
Innovation in Fungal Diagnostics
Thuy Le, MD, DPhil
Duke University; Oxford University Clinical Research Unit, United States / Vietnam
Innovations in HIV Self-Testing
Krittaporn Termvanich, MA
Institute of HIV Research and Innovation, Thailand
Parallel Session 4: Abstract-Driven Session - Treatment -
Chairs:
#6: Strongly Association of PNPLA3 rs738409 genotype on hepatic steatosis among non-obese people living with HIV
Tanakorn Apornpong
Thailand
#7: Noninferior efficacy, reduced weight gain, and improved lipid metabolism of switch to ainuovirine- versus boosted elvitegravir-based regimen in virologically suppressed people living with human immunodeficient virus 1: the 48-week results of the SPRIN
Fujie Zhang
China
#8: Week 96 Asian Sub-Analysis of a Phase 3 Randomized Controlled Trial of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) vs Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate (DTG + F/TDF) as Initial Treatment in HIV-1/HBV Coinfected A
Anchalee Avihingsanon
Thailand
#9: Dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate: Real-world Assessment of weight Gain in people living with HIV of Asian OrigiN (DRAGON study)
Cheng Chien-Yu
Taiwan
#10: Same-day treatment of sexually transmitted infections among people living with HIV: an opportunity to apply lessons learned from community-led clinics in Bangkok, Thailand
Artit Wongsa
Thailand
Guided Poster Tour - 11:45
11:45 HKT
Prevention matters – Advancing Testing Strategies
11:45 HKT
Achieving Quality of Life by Addressing Non-biomedical Needs of People Living with and Affected by HIV
Parallel Session 5: Women's Health - HPV -
Chairs:
Implementation / Policy of HPV Vaccination
Shenglan Tang, MD, MPH, PhD
Department of Population Health Science, Duke Medical School, USA / Duke Global Health Institute, USA / Global Health Research Center, Duke Kunshan University, China / SingHealth-Duke-NUS Global Health Institute, Singapore
Screening HPV - Rose Project
Woo Yin Ling, MB, BCh, MA, PhD
University of Malaya / University Malaya Medical Centre, Malaysia
Parallel Session 6: Abstract-Driven Session - Prevention -
Chairs:
#11: The Effectiveness of Co-Created Digital Intervention to Improve PrEP Adherence Among Chinese Men Who Have Sex with Men: A Stepped-wedge Randomized Trial in China
Chunyan Li
Japan
#13: Preferences for accessing pre-exposure prophylaxis among men who have sex in Australia
Warittha Tieosapjaroen
Australia
#14: Impact of changing PrEP regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023)
Hao Thi Minh Bui
Vietnam
#15: Assessing HIV prevention coverage among men who have sex with men (MSM) across 15 countries in Asia: Results from the PrEP APPEAL Study
Benjamin R Bavinton
Australia
DEBATE: Middle-Aged and Older Adults Living with HIV Should Be on a Statin -
Moderator:
Joseph Tucker, MD, PhD, AM
UNC Chapel Hill, United States
Pro Standpoint
Gary Han Siong Toh, MD, MSc, DTM&H
Chi Mei Medical Center, Taiwan
Con Standpoint
Sanjay Pujari, MD, MBBS
Institute of Infectious Diseases, Pune, India
Parallel Session 7: Adolescents Transitioning to Adult Care -
Chair:
Short Patient Reflection on How Perceived Support/Care
PHIN
Chulalongkorn University, Thailand
Managing Co-morbidities in Adolescents with Perinatally Acquired HIV
Tavitiya Sudjaritruk, MD, ScM, PhD
Chiang Mai University, Thailand
#16: Fully Integrated Mental Health Management within Routine HIV Adolescent and Young Adult Services using a Collaborative Care Model in Thailand: Lessons Learned
Wipaporn Natalie Songtaweesin
Thailand
Parallel Session 8: Abstract-Driven Session - Digital Innovations -
Chairs:
#17: Enhancing access to HIV, sexual and reproductive health, and gender-based violence services for female entertainment workers in Cambodia: a cluster randomized controlled trial of a mobile health intervention
Siyan Yi
Singapore
#18: Developing and evaluating an HIV self-testing service with online real-time counselling provided by an artificial intelligence Chatbot (HIVST-Chatbot)
Zixin Wang
Hong Kong
#102: Machine Learning Algorithms for Predicting HIV Infection among Young Men Who Have Sex with Men in Thailand
Krittaka Soha
Thailand
#108: A mobile health approach for facilitating regular HIV testing among men who have sex with men
Tsz Ho Kwan
Hong Kong

Day 3 - Saturday, 29 June 2024

Parallel Session 9: Long-acting ARV -
Implementation of Long Acting ARVs
Junko Tanuma, MD, PhD
International University of Health and Welfare, Chiba, Japan
Real-World Experience - Hong Kong
Owen Tsang, MBChB,MRCP,FHKCP,FHKAM,MTH,DTM&H,LSHTM,FRCP
Princess Margaret Hospital, Hong Kong
Real-World Experience - South Korea
Jun Yong Choi, MD, PhD
Yonsei University College of Medicine, Severance Hospital Seoul, South Korea
Parallel Session 10: Migrant Healthcare Challenges -
Chair:
Inequality in HIV Response in Asia Pacific
Migration and Transnational Sex Work in Asia
Vanessa Ho
Project X, Singapore
Plenary Session 3: Implementation of Decentralized Care -
Chairs:
Malaysia's Journey Implementation of Decentralized HCV Care Delivery.
Datuk Dr Hjh Rosaida binti Hj Md Said, MBBS (UM), MMED (UKM)
Hospital Sultan Idris Shah Serdang, Malaysia
#20: Integrating hepatitis C virus self-testing into HIV and harm reduction services as an approach towards HCV micro-elimination among key populations and people living with HIV in Vietnam
Bao Vu Ngoc
Viet Nam
Decentralized Infant Diagnosis & Viral Load Testing
Angela Kelly-Hanku, BA (Hons), PhD
Kirby Institute, UNSW Sydney, Australia and Papua New Guinea Institute of Medical Research, Papua New Guinea
#21: Outcomes from a community-clinic hybrid PrEP approach as part of a clinical trial in China, 2021-2023
Zhuoheng Yin
China
Plenary Session 4: Integrated Healthcare / Task Shifting -
Hepatitis Care: Integration in Primary Care
Beng Eu, MBBS
Prahran Market Clinic / Melbourne Medical School / University of Melbourne, Australia
The Role of Nurses in HIV Care
Shan Chan, RN, MSN, FHKAN (Infectious Disease-Medicine)
Queen Elizabeth Hospital, Hong Kong, China
The Role of Pharmacists in HIV Care
Preethi Raghaven, MPharm
Hospital Sungai Buloh, Malaysia
12:30 HKT
Closure of the Meeting
Overview
Thank you
APACC 2024 group photo

We are pleased to reflect on the highly successful APACC 2024 which took place in Hong Kong Convention and Exhibition Centre on 27-29 June 2024.  

The Program Chair and Organizers would like to thank the speakers and all participants for their contribution to this conference!

Special thanks to the conference support and endorsers. Without their contribution, this conference would not have been made possible.

To stay updated on developments about APACC 2025, make sure you sign up for our newsletter.

Program Chairs 2024
General Information 
Who Should Attend?
- Residents, post-graduates, and PhD students;

- Government agency personnel, NGO representatives, and health authority personnel;

- Industry representatives;

- Social workers, advocates, and community workers; and

- Other healthcare professionals involved in treating HIV and co-infected patients.
Meeting Objectives
This meeting aimed to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;

- Create a platform for interactive information exchange on novel treatment strategies and options;

- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV.
Learning Objectives
After participating in this meeting, participants would be able to:

- Describe the similarities and differences between the different international/ regional treatment guidelines;

- Select optimal treatment strategies for their patients understanding the various clinical parameters affecting the choice of regimens;

- Recall to latest developments for HIV prevention;

- Discuss the suitability of oral versus intramuscular injections for prevention/treatment;

- Summarize and compare the options for starting antiretroviral treatment;

- Describe the concept of early diagnosis and rapid start;

- Review the treatment options for patients failing on their current regimen.
AIDS 2024
APACC 2024 was an AIDS 2024 Affiliated Independent Event.
Practical Information 
Venue
The APACC 2024 was taken place in Hong Kong Convention and Exhibition Centre, Hong Kong.

The address was:
Hong Kong Convention and Exhibition Centre
1 Expo Drive,
Wan Chai,
Hong Kong

Distance from Hong Kong International Airport: 39 km
Distance from MTR Wan Chai Station: 550m, about 7 mins walk
Distance from MTR Exhibition Centre Station: 230m, about 3 mins walk
Entry Requirements
All travelers arriving to Hong Kong, are required to possess a valid travel document to entry Hong Kong.
See here: https://www.gov.hk/en/nonresidents/visarequire/general/index.htm
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-conference survey.
Language
The official language of the meeting is English.
Enduring Materials
Enduring materials will be available to all registered delegates on the virtual conference portal for 3 weeks after the conference. After this, all presentations will be made publicly available on this website (pending the approval of the speakers).
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

Registration for APACC 2025 is open!

For more details, please visit the conference website for APACC 2025. 

Committees
Program Chairs 2024
Organizing Committee
Hung, Chien-Ching 2023
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee
APACC Fellows (2023-2024)

The purpose of the APACC Fellows Program is to provide early-career investigators with an opportunity to learn about HIV and co-infection research, conference organization, and leadership through serving on the Organizing Committee of APACC. Fellows will help to develop conference session content for other early-career investigators and promote APACC over a two-year term. The Organizing Committee is responsible for the overall content of the conference program, driving conference engagement, and selecting abstracts and panel topics. Fellows will receive support to attend the conference for each of the two years in which they participate (remotely or in-person, as appropriate). 

APACC Fellows (2025-2026)
Scientific Program Coordinator
Fellowship
Outgoing Fellows Experiences

Rodenie Arnaiz Olete, MSc, RN

Rod

"Embracing the APACC 2023-2024 fellowship was a journey of growth. I had the privilege of shaping my own conference workshops, contributing to research as a peer reviewer of submitted abstracts, and collaborating on the conference program. It's not just a fellowship; it's a chance to evolve in a supportive community, where your contributions matter and connections thrive. Joining the APACC fellowship program opens doors to meaningful experiences, making your early-career journey richer and more rewarding."

Pui Li Wong, MBChB, MRCP(UK)

wong

"This fellowship has given me the opportunity to learn from experienced researchers and clinicians how large regional conferences are put together . It has also given me a platform to speak about topics that I am passionate about through the capacity-building sessions, with valuable guidance and mentorship from the faculty. Furthermore, meeting and working with the other fellows with different interests and viewpoints was exciting and inspiring."

Chunyan Li, MSc, PhD

Chunyan

"Working with a global team of esteemed experts in HIV research to coordinate and plan APACC has proven to be an enlightening experience. This opportunity allows me to keep up with the latest research trends across diverse fields (that otherwise I might get less exposure to in my daily work), expand my professional network, and most importantly – observe and learn how to facilitate the intellectual exchange in this field via organizing academic conferences like APACC. As an early-career fellow, we feel free to ask questions or propose ideas without fearing being judged or dismissed in such a supportive atmosphere where the senior members exhibit a remarkable openness to engage with junior fellows. Every individual (from committee chairs to administrative staff) and each interaction underscores a collective commitment to the sincere goal of eradicating HIV in the Asia-Pacific region."

Support
Platinum Level
Contributor Level
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV and co-infections with HIV.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause and get in touch with us for a tailored support package for APACC 2025, please contact Ting-Wen Cheng at ting-wen.cheng@amededu.com.
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Endorsers

APACC 2024 was endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!

If you would like your organization to endorse APACC 2025, please contact Andrés (Yuxuan) Ma at yuxuan.ma@amededu.com.

Endorsers
Accreditation

APACC 2024 was accredited by the following societies. To claim the CME points, members of the societies must either log on to the virtual congress portal, or sign up on the attendance sheet onsite, and attend the full sessions. Additional information such as membership number or license number might be required after the event.

The Japanese Society for AIDS Research
JSAR logo@0.5x

APACC 2024 has been accredited by the Japanese Society for AIDS Research (JSAR) with 5 CME credits. To claim these CME points, JSAR member physician will need to submit their conference badge to JSAR for validation.

日本エイズ学会認定医・指導医制度 細則3認定の要件1(3)④に基づき、APACC参加者には認定医・指導医取得・更新のための点数5点が付与されます。

European Accreditation Council for Continuing Medical Education (EACCME)
EACCME

The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024, Hong Kong, Hong Kong 27/06/2024 - 29/06/2024 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Taiwan AIDS Society
Taiwan AIDS Society

APACC 2024 is accredited by the Taiwan AIDS Society with 4 credits. To claim the CME points, members of the Taiwan AIDS Society must log on to the virtual congress portal or sign up on the attendance sheet onsite and attend the full sessions.  

Hong Kong Academy of Medicine (HKAM)
HKAM.jpg

APACC 2024 is accredited by the Hong Kong Academy of Medicine (HKAM) for 14.5 credits. To claim the CME points, members of the HKAM must attend the full sessions in-person or log on to the virtual congress portal and attend the full sessions.

Previous Editions
Language
Ratings previous edition
Overall event experience
4.6
(249)
Content is relevant to my practice
4.5
(249)
Content was presented clearly
4.5
(249)
Content was free from commercial bias
4.3
(249)